Search Results

Select result number 1
1

NGS-Based ctDNA Profiling After the Resistance of Second-Line Osimertinib for Patient with EGFR-Mutated Pulmonary Adenocarcinoma

by Li,Dan, Yang,DaFu, Cui,SaiQiong, Pan,Evenki, Yang,Peng, Dai,ZhaoXia
Published in OncoTargets and Therapy (2021)
“... are heterogeneous. Here, we report that a lung adenocarcinoma patient with EGFR L858R mutation who was treated...”

Get access

Article in Journal/Newspaper
Select result number 2
2

NGS-Based ctDNA Profiling After the Resistance of Second-Line Osimertinib for Patient with EGFR-Mutated Pulmonary Adenocarcinoma

by Li D, Yang D, Cui S, Pan E, Yang P, Dai Z
Published 2021
Subjects: “...lung adenocarcinoma...”

Get access

Article in Journal/Newspaper
Select result number 3
3

Tumor Heterogeneity and Drug Resistance Mutations Using ctDNA in Metastatic EGFR Mutation-Positive Lung Adenocarcinoma: A Case Report

by Sun,Jinghua, Sun,Ge, Lu,KeMou, Xu,Lingling, Qu,XiaoNa, Cheng,Ye, Pan,Evenki, Yang,Peng, Wu,Tingting, Zhang,Yang, He,HongMei
Published in OncoTargets and Therapy (2022)
“.... Here, we reported a lung adenocarcinoma (LADC) with EGFR mutations who was treated with sequential EGFR...”

Get access

Article in Journal/Newspaper
Select result number 4
4

Tumor Heterogeneity and Drug Resistance Mutations Using ctDNA in Metastatic EGFR Mutation-Positive Lung Adenocarcinoma: A Case Report

by Sun J, Sun G, Lu K, Xu L, Qu X, Cheng Y, Pan E, Yang P, Wu T, Zhang Y, He H
Published 2022
“..., we reported a lung adenocarcinoma (LADC) with EGFR mutations who was treated with sequential EGFR...”

Get access

Article in Journal/Newspaper

Narrow Search